Naltrexone and communication skills in young children with autism

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 38, Issue 5, 1999, Pages 587-593

  Feldman, Heidi M ^a   Kolmen, Barbara K ^b   Gonzaga, Alda Maria ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Communication; Language; Naltrexone; Psychopharmacology

Indexed keywords

NALTREXONE; OPIATE ANTAGONIST; PLACEBO;

ARTICLE; AUTISM; CHILD; CHILD PARENT RELATION; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INTERPERSONAL COMMUNICATION; LANGUAGE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERBAL COMMUNICATION;

EID: 0032946773     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199905000-00021     Document Type: Article

References (46)

1. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington, DC: American Psychiatric Association
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-1V). Washington, DC: American Psychiatric Association
3. Brahen LS, CaponeTJ, Capone DM (1988), Naltrexone: lack of effect on hepatic enzymes. J Clin Pharmacol 28:64-70
4. Campbell M, Adams P, Small AM, Tesch LM, Curren EL (1988), Naltrexone in infantile autism. Psychopharmacol Bull 24:135-139
5. Campbell M, Anderson LT, Small AM, Adams P, Gonzalez NM, Ernst M (1993), Naltrexone in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry 32:1283-1291
6. Campbell M, Overall JE (1989), Diagnostic criteria and behavior patterns in infantile autism. Psychopharmacol Bull 25:194-197
7. Chamberlain RS, Herman BH (1990), A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism. Biol Psychiatry 28:773-793
8. Eales MJ (1993), Pragmatic impairments in adults with childhood diagnoses of autism or developmental receptive language disorder. J Autism Dev Disord 23:593-617
9. Frith U (1989), A new look at language and communication in autism. Br J Disord Commun 24:123-150
10. Herman BH (1990), A possible role of proopiomelanocortin peptides in self-injurious behavior. Prog Ncuropsychopharmacol Biol Psychiatry 14(suppl): S109-S139
11. Herman BH, Hammock MK, Arthur-Smith Aet al. (1987), Naltrexone decreases self-injurious behavior. Ann Neurol 22:550-552
12. Herman BH, Hammock MK, Arthur-Smith A, Kuehl K, Appelgate K (1989), Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children. Dev Pharmacol Ther 12:118-127
13. Kolmen BK, Feldman HM, Handen BL, Janosky JE (1995), Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study. J Am Acad Child Adolesc Psychiatry 34:223-231
14. Kolmen BK, Feldman HM, Handen BL, Janosky JE (1997), Naltrexone in young autistic children: replication study and learning measures. J Am Acad Child Adolesc Psychiatry 36:1570-1578
15. Landa R, Piven J, Wzorek MM, Gayle JO, Chase GA, Folstein SE (1992), Social language use in parents of autistic individuals. Psychol Med 22:245-254
16. Leboyer M, Bouvard MP, Dugas M (1988), Effects on nalttexone on infantile autism (letter). Lancet 1:715
17. Leiter R (1948), Leiter International Performance Scales, Los Angeles: Western Psychological Services
18. Loveland KA, Landry SH (1986), Joint attention and language in autism and developmental language delay. J Autism Dev Disord 16:335-349
19. Loveland KA, Landry SH, Hughes SO, Hall SK, McEvoy RE (1988), Speech acts and the pragmatic deficits of autism. J Speech Hear Res 31:593-604
20. MacWhinney B (1991), The CHILDES Project: Tools for Analyzing Talk. Hillsdale, NJ: Erlbaum
21. McEvoy RE, Loveland KA, Landry SH (1988), The functions of immediate echolalia in autistic children: a developmental perspective. J Autism Dev Disoni 18:657-668
22. Minshew NJ, Payton JB (1988), New perspectives in autism, part II: the differential diagnosis and neurobiology of autism (review). Girr Probl Pediatr 18:613-694
23. Mundy P, Sigman M, Kasari C (1990), A longitudinal study of joint attention and language development in autistic children. J Autism Dev Disant 20:115-128
24. National Institute of Mental Health (1985), Special feature: rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:839-842
25. Nordin V, Gillberg C (1998), The long-term course of autistic disorders: update on follow-up studies. Acta Psychiatr Scand 97:99-108
26. Panksepp J, Herman BH, Vilberg T, Bishop P, DeEskinazi FG (1980), Endogenous opioids and social behavior. Neurosci Biobehav Rev 4:473-487
27. Panksepp J, Lensing P (1991), Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children. J Autism Dev Disord 21:243-249
28. Pfohl DN, Alien JI, Atkinson RLet al. (1986), Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage. NIDA Res Monogr 67:66-72
29. Prizant BM (1996), Brief report: communication, language, social, and emotional development. J Autism Dev Disord 26:173-178
30. Rapin I (1997), Autism. N Enigl J Med 337:97-104
31. Roberts JM (1989), Echolalia and comprehension in autistic children. J Autism Dev Disord 19:271-281
32. Rogers S, D'Eugenio D (1981), Developmental Programming for Infants and Young Children, Assessment and Application-Revised. Ann Arbor, MI: University of Michigan Press
33. Sandman CA (1988), Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis. Synapse 2:193-199
34. Schopler E, Reichler RJ, DeVellis RF, Daly K (1980), Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 10:91-103
35. Sparrow S, Dalla B, Cicchetti D (1984), Vineland Adaptive Behavior Scales. Circle Pines, MN: American Guidance Service
36. Spiegel TA, Stunkard AJ, Shrager EE, O'Brien CP, Morrison MF, Stellar E (1987), Effect of naltrexone on food intake, hunger, and satiety in obese men. Physiol Behav 40:135-141
37. Tager-Flusberg H (1994), Dissociations in form and function in the acquisition of language by autistic children. In: Constraints on Language Acquisition: Studies of Atypical Children, Tager-Flusberg H, ed. Hillsdale, NJ: Erlbaum, pp 175-195
38. Thurber C, Tager-Flusberg H (1993), Pauses in the narratives produced by autistic, mentally retarded, and normal children as an index of cognitive demand. J Autism Dev Disord 23:309-322
39. Tsai LY (1996), Brief report: comorbid psychiatric disorders of autistic disorder. J Autism Dev Disord 26:159-163
40. Verebey KG, Mule SJ (1986), Naltrexone (Trexan): a review of hepatotoxicity issues. NIDA Res Monogr 67:73-81
41. Walters AS, Barrett RP, Feinstein C, Mercurio A, Hole WT (1990), A case report of naltrexone treatment of self-injury and social withdrawal in autism. J Autism Dev Disord 20:169-176
42. Wetherby AM (1986), Ontogeny of communicative functions in autism. J Autism Dev Disord 16:295-316
43. Willemsen-Swinkels SH, Buitelaar JK, Nijhof GJ, van Engeland H (1995a), Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults: double-blind placebo-controlled studies. Arch Gen Psychiatry 52:766-773
44. Willemsen-Swinkels SH, Buitelaar JK, van Engeland H (1996), The effects of chronic naltrexone treatment in young autistic children: a doubleblind placebo-controlled crossover study. Biol Psychiatry 39:1023-1031
45. Willemsen-Swinkels SH, Buitelaar JK, Weijnen FG, van Engeland H (1995b), Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatry Res 58:203-215
46. Zingarelli G, Ellman G, Horn A, Wymore M, Heidorn S, Chicz-DeMet A (1992), Clinical effects of naltrexone on autistic behavior. Am J Ment Retard 97:57-63